BackGreenLight Biosciences- Warrants (30/09/2027) Overview
GreenLight Biosciences Inc - Warrants (30/09/2027)

GreenLight Biosciences- Warrants (30/09/2027) Return on Equity

Valuation check: GRNAW's ROE is -720.61%, below the sector sector average of -5.84%.

Get informed when a big investor buys or sells

+ Follow

ROE

-720.61%

Return on Equity

-720.61%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

GreenLight Biosciences- Warrants (30/09/2027) posts a ROE of -720.61%. That is below the sector sector average of -5.84%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -5.84% is typical. GreenLight Biosciences- Warrants (30/09/2027)'s -720.61% is lower that level. That is roughly 12228.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

GreenLight Biosciences- Warrants (30/09/2027)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -720.61%; use YoY and peer views to separate noise from signal.

Context for GRNAW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.84%), and (3) consistency with growth and profitability. This page covers the first two; GreenLight Biosciences- Warrants (30/09/2027)'s other metric pages and overview cover the third.